A detailed history of Td Asset Management Inc transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 164,078 shares of CLDX stock, worth $4.12 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
164,078
Previous 189,678 13.5%
Holding current value
$4.12 Million
Previous $7.02 Million 20.6%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$32.06 - $44.56 $820,736 - $1.14 Million
-25,600 Reduced 13.5%
164,078 $5.57 Million
Q2 2024

Aug 02, 2024

SELL
$32.76 - $42.56 $1.17 Million - $1.52 Million
-35,800 Reduced 15.88%
189,678 $7.02 Million
Q1 2024

May 08, 2024

BUY
$35.22 - $51.88 $6.1 Million - $8.98 Million
173,156 Added 330.94%
225,478 $9.46 Million
Q4 2023

Feb 12, 2024

SELL
$22.61 - $40.65 $284,886 - $512,190
-12,600 Reduced 19.41%
52,322 $2.08 Million
Q3 2023

Oct 27, 2023

BUY
$25.45 - $37.46 $826,132 - $1.22 Million
32,461 Added 100.0%
64,922 $1.79 Million
Q2 2023

Aug 09, 2023

SELL
$30.29 - $38.28 $402,857 - $509,124
-13,300 Reduced 29.06%
32,461 $1.1 Million
Q1 2023

May 10, 2023

SELL
$34.78 - $47.43 $330,410 - $450,585
-9,500 Reduced 17.19%
45,761 $1.65 Million
Q4 2022

Feb 06, 2023

BUY
$27.78 - $45.38 $211,128 - $344,888
7,600 Added 15.95%
55,261 $2.46 Million
Q3 2022

Nov 07, 2022

BUY
$22.7 - $37.57 $249,700 - $413,270
11,000 Added 30.0%
47,661 $1.35 Million
Q2 2022

Aug 04, 2022

SELL
$20.5 - $37.33 $761,944 - $1.39 Million
-37,168 Reduced 50.34%
36,661 $988,000
Q1 2022

May 10, 2022

BUY
$27.64 - $39.32 $317,860 - $452,180
11,500 Added 18.45%
73,829 $2.52 Million
Q3 2021

Nov 09, 2021

BUY
$28.95 - $55.99 $503,730 - $974,226
17,400 Added 38.73%
62,329 $3.37 Million
Q2 2021

Aug 11, 2021

BUY
$20.71 - $35.37 $457,256 - $780,934
22,079 Added 96.63%
44,929 $1.97 Million
Q1 2021

May 14, 2021

BUY
$16.19 - $29.91 $104,425 - $192,919
6,450 Added 39.33%
22,850 $471,000
Q4 2020

Feb 16, 2021

BUY
$14.99 - $22.75 $245,836 - $373,100
16,400 New
16,400 $287,000

Others Institutions Holding CLDX

About Celldex Therapeutics, Inc.


  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.18B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.